In a bombshell declaration that could reshape the national vaccination debate, former Centers for Disease Control and Prevention Director Dr. Robert Redfield has called for the complete withdrawal of mRNA COVID-19 vaccines manufactured by Pfizer and Moderna from public use.
The stunning recommendation came during an exclusive interview with EpochTV’s “American Thought Leaders” program, set to air December 9, where the former top health official expressed deep reservations about the continued deployment of these widely-administered vaccines.
“I really would like to see the mRNA vaccine use curtailed, and personally, I’d like to see it eliminated, because I think there’s too many unknowns,” Redfield stated emphatically during the candid discussion.
Redfield’s explosive comments mark a dramatic departure from the mainstream medical establishment’s position on mRNA vaccines, which have been administered to hundreds of millions of Americans since their emergency authorization in late 2020. His stance carries particular weight given his prominent role leading the CDC during the critical early phase of the COVID-19 pandemic under the Trump administration.
The former CDC director’s call for elimination of mRNA vaccines represents one of the most significant challenges to current vaccination policy from a high-ranking former federal health official. His concerns about “too many unknowns” surrounding the technology suggest ongoing uncertainty about long-term effects and safety profiles of these revolutionary vaccines.
This development comes at a time when vaccine policy continues to generate intense public debate, with various medical professionals and researchers raising questions about the risk-benefit analysis of continued mRNA vaccine deployment, particularly for certain demographic groups.
Redfield’s position stands in stark contrast to current CDC guidance, which continues to recommend COVID-19 vaccination for eligible populations. The agency he once led maintains that the benefits of vaccination outweigh potential risks for most individuals.
The timing of these remarks is particularly noteworthy as the medical community grapples with emerging data on vaccine effectiveness and safety signals that have prompted ongoing scientific discussion and regulatory review processes worldwide.
As the full interview awaits release, Redfield’s unprecedented call for mRNA vaccine withdrawal is likely to intensify existing debates about vaccine policy, regulatory oversight, and the balance between public health measures and individual medical choice in post-pandemic America.
